Avantax Planning Partners’s QuidelOrtho QDEL Stock Holding History

Avantax Planning Partners’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-44	Closed	-$3K	–	981
2018 Q3	$3K	Buy	+44	New	+$3.08K	﹤0.01%	1270
2018 Q2	–	Sell	-21	Closed	-$1K	–	1176
2018 Q1	$1K	Buy	+21	New	+$977	﹤0.01%	1738

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Avantax Planning Partners's QDEL Position: Q4 2018 in Review

Avantax Planning Partners sold out of QuidelOrtho (QDEL) in Q4 2018, closing a stake of 44 shares — an estimated $3K sold.

Avantax Planning Partners first reported a position in QDEL in Q1 2018 and held it in 2 quarters. The position peaked at $3K in Q3 2018. 158 funds tracked by Wall St. Rank hold QDEL as of Q4 2018.

Avantax Planning Partners reported no remaining QuidelOrtho position as of Q4 2018 after selling out during the quarter.
Avantax Planning Partners sold 44 QuidelOrtho shares in Q4 2018, an estimated $3K.
Avantax Planning Partners first reported a position in QuidelOrtho in Q1 2018 and held it in 2 quarters.
Avantax Planning Partners's QuidelOrtho position peaked at $3K in Q3 2018.
158 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2018.

Based on Avantax Planning Partners's 13F filing for Q4 2018, filed 14 Feb 2019.